Open AccessNationwide Implementation of Pathogen Inactivation for All Platelet Concentrates in Switzerland
Author(s) -
Markus Jutzi,
Behrouz Mansouri Taleghani,
Morven Rueesch,
Lorenz Amsler,
Andreas Buser
Publication year - 2018
Publication title -
transfusion medicine and hemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 39
eISSN - 1660-3818
pISSN - 1660-3796
DOI - 10.1159/000489900
Subject(s) - platelet , pathogen , medicine , blood preservation , intensive care medicine , immunology , biology , physiology
Bacterial contamination of platelet concentrates (PCs) has been identified as the most prevalent transfusion-associated infectious risk. To prevent PC-related septic transfusion reactions, the Intercept® pathogen inactivation procedure was introduced for all PCs in Switzerland in 2011.